Pall helps the Thai Red Cross

Published: 9-Feb-2004


By using an advanced purification technology from the Pall Corporation, the Thai Red Cross Society has significantly increased production and purity of equine antirabies immunoglobulins (ERIG), which are used to cure rabies in humans. Post-exposure treatment of rabies with antirabies immunoglobulins is still very important in order to reduce deaths in Thailand. Many companies in Europe have stopped production of equine rabies immunoglobulins and products are in short supply to hospitals. Pall's automated ultrafiltration technology reduces the time it takes to purify immunoglobulins from one week to one day, while increasing yield levels. The new technology enables Thailand to supply these critical ERIG to the Centers for Disease Control in Thailand for the first time. Pall's purification technology was part of a $4.5m modernisation of the Queen Saovabha Memorial Institute (QSMI), the manufacturing facility of the Thai Red Cross. The modernisation makes the Institute the first GMP-compliant biologics facility in Thailand, and it recently received GMP certification from the Thai Food and Drug Administration.

www.pall.com

You may also like